<DOC>
	<DOCNO>NCT00217178</DOCNO>
	<brief_summary>Study Objective : 1 . To evaluate whether combined therapy folic acid 2.5 mg/day , vitamin B6 50 mg/day vitamin B12 1000 micrograms/day v placebo reduces rate atherosclerosis progression , evaluate quantitative B-mode carotid ultrasound ( US ) .</brief_summary>
	<brief_title>Homocysteine Lowering Atherosclerosis Reduction Trial ( HART )</brief_title>
	<detailed_description>The HART study design substudy Heart Outcomes Prevention Evaluation-2 ( HOPE-2 ) trial evaluates effect combine therapy ? folic acid vitamin B6 B12 clinical event . The study design enrol 900 study participant randomize homocysteine lower therapy placebo . Follow-up estimate 5 year . Study participant undergo yearly carotid B-Mode ultrasound examination .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>Women Men age ≥ 55 year high risk CV event : ( ) Documented ( CAD ) : ) History prior MI ; ii ) stable unstable angina document multivessel CAD strongly positive stress test ; iii ) Multivessel CAD PTCA ≥ 6 month prior randomization ; iv ) multivessel CABG ≥ 4 year prior randomization ; v ) Multivessel CAD angiography ; ( b ) Documented peripheral vascular disease ( PVD ) : ) Previous limp bypass surgery and/or previous peripheral percutaneous transluminal angioplasty and/or previous limp foot amputation due PVD.ii ) History intermittent claudication ankle/arm blood pressure ratio ≤ 0.80 significant arterial stenosis angiography ; ( c ) Documented cerebrovascular disease : ) History previous ischemic stroke ; ( ) Diabetes mellitus ≥ 1 additional major CV risk factor ( ) . ( 2 ) Provision inform consent . ( 3 ) Adequate baseline carotid US examination . 1 . Current use folic acid supplement &gt; 200 mg/day . 2 . Known previous adverse reaction folic acid , Vitamin B6 B12 . 3 . Planned cardiac , peripheral cerebrovascular .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>CV Risk Factors</keyword>
	<keyword>Homocysteine</keyword>
	<keyword>CV disease</keyword>
	<keyword>Cardiovascular disease</keyword>
</DOC>